MAO-B-IN-9(Cat No.:I043684)is a potent and selective inhibitor of monoamine oxidase B (MAO-B), an enzyme primarily involved in the breakdown of neurotransmitters such as dopamine in the brain. By inhibiting MAO-B, this compound can help increase dopamine levels, which may offer therapeutic potential for neurodegenerative disorders like Parkinson’s disease. MAO-B-IN-9 has been studied for its neuroprotective effects, improving cognitive function and motor skills in preclinical models. Its selective action reduces the risk of side effects seen with non-selective MAO inhibitors, making it a promising candidate for Parkinson’s disease treatment.